ADVFN - ニュース

US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/07/13	05 : 37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FRZA	Forza X1 Inc
2024/07/13	05 : 37	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:HOOD	Robinhood Markets Inc
2024/07/13	05 : 37	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	NYSE:C	Citigroup Inc
2024/07/13	05 : 37	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NYSE:BODY	Beachbody Company Inc
2024/07/13	05 : 36	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:TECK	Teck Resources Ltd
2024/07/13	05 : 36	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:MMI	Marcus and Millichap Inc
2024/07/13	05 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNPS	Synopsys Inc
2024/07/13	05 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TTSH	Tile Shop Holdings Inc
2024/07/13	05 : 35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SPSC	SPS Commerce Inc
2024/07/13	05 : 35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:AOS	AO Smith Corp
2024/07/13	05 : 35	Business Wire	AM Best Downgrades Credit Ratings of New York Schools Insurance Reciprocal
2024/07/13	05 : 34	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/07/13	05 : 34	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TRDA	Entrada Therapeutics Inc
2024/07/13	05 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HII	Huntington Ingalls Industries Inc
2024/07/13	05 : 34	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:ACEL	Accel Entertainment Inc
2024/07/13	05 : 34	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:PNNT	PennantPark Investment Corporation
2024/07/13	05 : 34	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:SHIP	Seanergy Maritime Holdings Corporation
2024/07/13	05 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LDI	loanDepot Inc
2024/07/13	05 : 33	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:JPM-M	JP Morgan Chase and Co
2024/07/13	05 : 33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:ACEL	Accel Entertainment Inc
2024/07/13	05 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/07/13	05 : 33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:HNI	HNI Corporation
2024/07/13	05 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/07/13	05 : 33	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NYSE:BODY	Beachbody Company Inc
2024/07/13	05 : 33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VITL	Vital Farms Inc
2024/07/13	05 : 32	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALHC	Alignment Healthcare Inc
2024/07/13	05 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ALCC	AltC Acquisition Corp
2024/07/13	05 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:FSLY	Fastly Inc
2024/07/13	05 : 32	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FROG	JFrog Ltd
2024/07/13	05 : 31	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:JPM-M	JP Morgan Chase and Co

1 2 3 4 5 6 7 8 9 10 次へ >>

US Dollar vs Yen

American Express

US Dollar vs Euro

BNP Paribas (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約